scholarly article | Q13442814 |
P50 | author | Mel Krajden | Q6810759 |
Catharine Chambers | Q57259188 | ||
Yan Li | Q69032212 | ||
Nathalie Bastien | Q69032280 | ||
Hugues Charest | Q86870110 | ||
Gaston De Serres | Q86870133 | ||
Jonathan B Gubbay | Q87716515 | ||
Alireza Eshaghi | Q94927841 | ||
Danuta M. Skowronski | Q111259505 | ||
Suzana Sabaiduc | Q114718265 | ||
Martin Petric | Q114718266 | ||
Anne-Luise Winter | Q114718267 | ||
Kevin Fonseca | Q114718268 | ||
Paul Van Caeseele | Q114718272 | ||
Salaheddin M. Mahmud | Q42242293 | ||
James A Dickinson | Q42422634 | ||
P2860 | cites work | Live attenuated versus inactivated influenza vaccine in infants and young children. | Q55043222 |
SWISS-MODEL: An automated protein homology-modeling server | Q24672647 | ||
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. | Q30360290 | ||
Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada. | Q30364076 | ||
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains | Q30396902 | ||
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. | Q30399334 | ||
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses | Q30419865 | ||
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? | Q33990541 | ||
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation | Q34194336 | ||
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories | Q34332806 | ||
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season | Q34480810 | ||
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 | ||
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses | Q35130915 | ||
Quantifying influenza vaccine efficacy and antigenic distance. | Q35760689 | ||
Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines | Q37208841 | ||
Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. | Q41474318 | ||
Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses | Q41516523 | ||
Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs | Q41884668 | ||
Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. | Q42237299 | ||
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine | Q42242172 | ||
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution | Q42253862 | ||
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma | Q44070675 | ||
Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. | Q44243917 | ||
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants | Q45167252 | ||
The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses | Q45774432 | ||
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. | Q48071872 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | influenza vaccine | Q383260 |
P304 | page(s) | 726-739 | |
P577 | publication date | 2015-03-17 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | |
P478 | volume | 212 |